Skip to main content
. 2019 Jan 21;35(3):446–450. doi: 10.1007/s12288-018-01066-6

Table 1.

AML patients with different cytogenetic status

Cytogenetic results No. (%)
t(8;21)(q22;q22); RUNX1-RUNX1T1 13 (16.3%)
inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 12 (15%)
t(15;17)(q22;q12); PML-RARA 22 (27.5%)
t(9;11)(p22;q23); MLLT3-MLL 6 (7.5%)
Normal cytogenetic (CN-AML) 27 (33.7%)